Journalists

Journalists

Covering current events in science, the environment, technology and health requires a context and reliable sources that respond quickly.

¿Qué me ofrece?

When science hits the headlines, we publish reactions, explanations, and in-depth analysis from reliable sources, capturing both the evidence and the debates. Our library of science journalism resources and the briefings may be of use to you. Consult our directory of research centres.

Icono
Cómo trabajamos

We are on the lookout for any controversial information about science (embargoed or not), in order to react with the agility the media needs. Sign up to receive our embargoed contents, all under the Creative Commons licence. Find out more about how we work here.

Título qué me ofrece
What we offer you
Título cómo trabajamos
How we work

Reaction: Research estimates 15 million people at risk from glacial lake outburst floods

As rising temperatures melt glaciers, meltwater can accumulate and form lakes nearby. These bodies of water represent a natural hazard because of the floods they cause if they overflow. Researchers have estimated that 15 million people are at risk from these floods, and more than half of them live in just four countries: India, Pakistan, Peru and China. The research is published in Nature Communications.

0

Cancer vaccines: what they are, what they aren't and where we are now

News of cancer vaccines proliferate in the media, yet only one such vaccine has been approved - against metastatic prostate cancer - and is no longer in use. However, only one as such has been approved - against metastatic prostate cancer - and it is no longer in use. Are the attention and hopes justified? What do they consist of and how are they similar to traditional ones? Are they preventive or therapeutic? Can they be universal or will they be extremely personalised? How much will they cost? This is what we know today.

0

Reaction to study showing efficacy of meningitis B vaccine in under-fives in Spain

Researchers have analysed the efficacy of the meningococcal serogroup B vaccine (4CMenB, Bexsero) in more than 1,500 children under five years of age in Spain. The research, published in the New England Journal of Medicine, shows that full vaccination was effective in preventing invasive meningococcal disease of both serogroup B and other serogroups in this child population. The vaccine, which had been sold privately in Spain since 2015, had already been included by several autonomous communities in their vaccination schedules. Last December, the Interterritorial Council of the National Health System (CISNS) approved its inclusion in the vaccination schedule for the whole of Spain.

0

Reactions to research linking beta-blocker treatment with lower rates of violence

Beta-blockers (β-blockers) are drugs to treat heart conditions that are also used for anxiety. According to research published in PLOS Medicine, periods of treatment with these drugs are associated with a lower risk of being charged by the police with a violent crime - a 13% lower risk than periods without treatment. The research, which included nearly 1.5 million people in Sweden between 2006 and 2013, does not support the use of these drugs to treat anxiety.

0

Why ChatGPT cannot sign scientific articles

Nature's ban on publishing papers written by ChatGPT has brought several debates to the table: is it ethical to use it to produce science texts, and if so, should it sign them? Just as we don't make the Word proofreader a co-author of our articles, let's not make fools of ourselves by giving these new tools the status of co-authors as if they had an entity of their own.

1

Reactions: pandemic caused educational delays equivalent to a third of the academic year

A meta-analysis of 42 studies from 15 countries, including Spain, concludes that the covid-19 pandemic caused learning delays in school-aged children and a loss of knowledge equivalent to 35% of the learning of a school year. The research, published in Nature Human Behaviour, highlights that these effects persisted over time.

0